Get the Stockscreener App
1.20
0.84%
+0.01
Aptose Biosciences Inc Stock (APTO) Forecast
The Aptose Biosciences Inc (APTO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.3378, representing a +11.48% increase from the current price of $1.20. The highest analyst price target is $1.8099, and the lowest is $0.8657.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month APTO Price Target
Average 4.6148
(+284.57% Upside)
Is Aptose Biosciences Inc (APTO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.05 | Neutral |
| STOCH(9,6) | 38.24 | Neutral |
| STOCHRSI(14) | 92.10 | Sell |
| MACD(12,26) | -0.0874 | Buy |
| ADX(14) | 30.11 | Sell |
| William %R | -73.68 | Neutral |
| CCI(14) | -65.25 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.209
Sell
|
1.2207
Sell
|
| MA20 |
1.2701
Sell
|
1.2788
Sell
|
| MA50 |
1.4782
Sell
|
1.4805
Sell
|
| MA100 |
1.8287
Sell
|
1.7838
Sell
|
| MA200 |
2.5282
Sell
|
1.9394
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, APTO could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on APTO, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.05 indicates that APTO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 38.24 indicates that APTO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 92.1 indicates that APTO is oversold. This suggests that APTO price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.11 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -65.25 indicates that APTO is still oversold but not to an extreme extent.
Long-term APTO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aptose Biosciences Inc financial reports and earnings history, Aptose Biosciences Inc (APTO) stock could reach $0.3872 by 2030, $1.3609 by 2040 and $2.4275 by 2050. See the projected annual prices until 2050 of the Aptose Biosciences Inc stock below:
- Aptose Biosciences Inc (APTO) is expected to reach an average price of $1.2361 in 2035, with a high prediction of $2.1704 and a low estimate of $1.2361. This indicates an $3.01% rise from the last recorded price of $1.20.
- Aptose Biosciences Inc (APTO) stock is projected to chart a bullish course in 2040, with an average price target of $1.3782, representing an $14.85% surge from its current level. The forecast ranges from a conservative $1.3334 to a sky-high $1.3609.
- Our analysts predict Aptose Biosciences Inc (APTO) to jump 74.39% by 2045, soaring from $2.0128 to an average price of $2.0926, potentially reaching $2.0645. While $2.0128 is the low estimate, the potential upside is significant.
- Aptose Biosciences Inc (APTO) stock is expected to climb by 2050, reaching an average of $2.3504, a $95.87% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.4275 and $2.4278, respectively, highlighting the market's uncertainty.
Aptose Biosciences Inc Stock (APTO) Year by Year Forecast
Aptose Biosciences Inc Stock (APTO) Price Forecast for 2024
Our forecast for APTO stock price in 2024 now indicates an average price target of $1.7328 with a high forecast of $2.60 and a low forecast of $0.8657. The average prediction reflects an increase of +44.40% from the last recorded price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.6749 | $0.8657 | $1.8099 | +39.58% |
| July, 2024 | $1.6171 | $1.3371 | $2.1942 | +34.75% |
| August, 2024 | $1.3827 | $1.1799 | $1.8913 | +15.23% |
| September, 2024 | $1.4484 | $1.2842 | $1.817 | +20.70% |
| October, 2024 | $1.0705 | $0.9727 | $1.4898 | -10.79% |
| November, 2024 | $1.4512 | $0.947 | $1.5312 | +20.93% |
| December, 2024 | $1.628 | $1.4126 | $1.9155 | +35.67% |
Aptose Biosciences Inc Stock (APTO) Price Forecast for 2025
Aptose Biosciences Inc Stock (APTO) is expected to reach an average price of $5.1411 in 2025, with a high prediction of $8.364 and a low estimate of $1.9183. This indicates an +328.43% rise from the last recorded price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.494 | $1.9183 | $5.144 | +274.50% |
| February, 2025 | $5.8865 | $4.1459 | $6.1497 | +390.54% |
| March, 2025 | $6.9904 | $5.9854 | $8.364 | +482.53% |
| April, 2025 | $5.1025 | $3.3896 | $7.8618 | +325.21% |
| May, 2025 | $7.3962 | $4.6639 | $7.8167 | +516.35% |
| June, 2025 | $7.0038 | $5.591 | $8.1338 | +483.65% |
| July, 2025 | $5.891 | $5.611 | $7.6153 | +390.91% |
| August, 2025 | $5.1666 | $5.1166 | $6.4424 | +330.55% |
| September, 2025 | $4.1023 | $3.9409 | $5.4981 | +241.86% |
| October, 2025 | $4.6594 | $3.9158 | $5.3194 | +288.29% |
| November, 2025 | $5.1651 | $4.4309 | $5.7123 | +330.43% |
| December, 2025 | $3.6622 | $3.4822 | $5.4065 | +205.19% |
Aptose Biosciences Inc Stock (APTO) Price Forecast for 2026
The predicted value for Aptose Biosciences Inc (APTO) in 2026 is set at an average of $3.9284. Estimates vary from a peak of $6.4507 to a trough of $1.4061, indicating an +227.37% surge from the present price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.4579 | $3.5751 | $5.6379 | +354.83% |
| February, 2026 | $3.3336 | $3.1036 | $6.4507 | +177.80% |
| March, 2026 | $3.5893 | $3.1364 | $3.8829 | +199.11% |
| April, 2026 | $3.5064 | $3.2671 | $4.06 | +192.20% |
| May, 2026 | $3.1021 | $2.5893 | $3.6978 | +158.51% |
| June, 2026 | $4.4577 | $2.8535 | $6.4035 | +271.48% |
| July, 2026 | $4.0749 | $3.7249 | $5.052 | +239.57% |
| August, 2026 | $2.9805 | $2.8305 | $5.0032 | +148.38% |
| September, 2026 | $2.4576 | $2.3976 | $3.222 | +104.80% |
| October, 2026 | $2.0783 | $1.7819 | $2.4991 | +73.19% |
| November, 2026 | $2.229 | $1.5562 | $2.309 | +85.75% |
| December, 2026 | $1.4361 | $1.4061 | $2.3654 | +19.68% |
Aptose Biosciences Inc Stock (APTO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aptose Biosciences Inc (APTO) is $1.0339, with a high forecast of $2.0375 and a low forecast of $0.0304. This indicates an -13.84% decrease from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4268 | $1.3588 | $1.6304 | +18.90% |
| February, 2027 | $1.7675 | $1.2732 | $2.0375 | +47.29% |
| March, 2027 | $0.7646 | $0.3446 | $1.8489 | -36.28% |
| April, 2027 | $0.6103 | $0.5603 | $0.8189 | -49.14% |
| May, 2027 | $0.486 | $0.3631 | $0.6316 | -59.50% |
| June, 2027 | $0.4031 | $0.3802 | $0.5874 | -66.41% |
| July, 2027 | $0.6488 | $0.2859 | $0.6738 | -45.94% |
| August, 2027 | $0.4444 | $0.3844 | $0.8416 | -62.96% |
| September, 2027 | $0.2547 | $0.1987 | $0.5273 | -78.77% |
| October, 2027 | $0.1334 | $0.0772 | $0.3544 | -88.88% |
| November, 2027 | $0.1529 | $0.0432 | $0.2287 | -87.26% |
| December, 2027 | $0.1419 | $0.0304 | $0.24 | -88.17% |
Aptose Biosciences Inc Stock (APTO) Price Forecast for 2028
In 2028, Aptose Biosciences Inc (APTO) is projected to reach an average price of $2.9954, with a high projection of $5.9898 and a low estimate of $0.000975. This indicates an +149.61% rise from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0929 | $0.0756 | $0.2014 | -92.26% |
| February, 2028 | $0.0736 | $0.00155 | $0.1251 | -93.87% |
| March, 2028 | $0.201 | $0.1022 | $0.1629 | -83.25% |
| April, 2028 | $0.0461 | $0.0202 | $0.1313 | -96.16% |
| May, 2028 | $0.1927 | $0.000975 | $0.0917 | -83.94% |
| June, 2028 | $0.037 | $0.0135 | $0.1156 | -96.92% |
| July, 2028 | $0.0627 | $0.0227 | $0.1327 | -94.78% |
| August, 2028 | $0.1004 | $0.0141 | $0.1091 | -91.63% |
| September, 2028 | $0.0746 | $0.026 | $0.049 | -93.79% |
| October, 2028 | $0.0789 | $0.1439 | $0.1203 | -93.43% |
| November, 2028 | $0.1818 | $0.1474 | $0.1718 | -84.85% |
| December, 2028 | $4.0339 | $0.1873 | $5.9898 | +236.16% |
Aptose Biosciences Inc Stock (APTO) Price Forecast for 2029
The 2029 price forecast for Aptose Biosciences Inc Stock (APTO) is $2.333 on average, with a high prediction of $4.5053 and a low estimate of $0.1608. This represents an +94.42% increase from the previous price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.501 | $2.311 | $4.2353 | +108.42% |
| February, 2029 | $3.4167 | $2.5125 | $4.5053 | +184.73% |
| March, 2029 | $2.7024 | $2.7024 | $3.666 | +125.20% |
| April, 2029 | $1.5581 | $1.5581 | $2.9338 | +29.84% |
| May, 2029 | $1.8753 | $1.5705 | $2.7452 | +56.27% |
| June, 2029 | $2.0909 | $1.6495 | $2.3966 | +74.24% |
| July, 2029 | $1.9766 | $1.6951 | $2.34 | +64.71% |
| August, 2029 | $1.4437 | $1.1346 | $2.0394 | +20.31% |
| September, 2029 | $1.3093 | $1.2193 | $1.6465 | +9.11% |
| October, 2029 | $1.0065 | $0.815 | $1.3908 | -16.13% |
| November, 2029 | $0.6931 | $0.6621 | $1.1796 | -42.24% |
| December, 2029 | $0.26 | $0.1608 | $0.7416 | -78.33% |
Aptose Biosciences Inc Stock (APTO) Price Forecast for 2030
Aptose Biosciences Inc Stock (APTO) is expected to reach an average price of $3.7559 in 2030, with a high forecast of $7.4779 and a low forecast of $0.0339. This signifies an +212.99% surge from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3542 | $0.0415 | $0.3872 | -70.48% |
| February, 2030 | $0.8656 | $0.1171 | $1.1827 | -27.87% |
| March, 2030 | $0.547 | $0.4041 | $1.2584 | -54.42% |
| April, 2030 | $0.5883 | $0.2498 | $0.9626 | -50.97% |
| May, 2030 | $0.2325 | $0.1925 | $0.894 | -80.62% |
| June, 2030 | $0.2539 | $0.0339 | $0.4354 | -78.84% |
| July, 2030 | $0.7581 | $0.1467 | $0.8553 | -36.82% |
| August, 2030 | $3.4795 | $0.6238 | $3.6445 | +189.96% |
| September, 2030 | $4.0409 | $3.2514 | $4.5009 | +236.74% |
| October, 2030 | $6.4051 | $3.5494 | $6.9951 | +433.76% |
| November, 2030 | $3.2764 | $2.5365 | $7.4779 | +173.04% |
| December, 2030 | $4.0328 | $2.5093 | $4.715 | +236.07% |
1.62%
0.15%
Cap:
|
Volume (24h):